| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |